NIR‐II‐Responsive Hybrid System Achieves Cascade‐Augmented Antitumor Immunity via Genetic Engineering of Both Bacteria and Tumor Cells
Advanced Materials · 2024
DOI: 10.1002/adma.202407927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Xiaoguang Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Key Laboratory of Biomedical Materials of Natural Macromolecules, Beijing Laboratory of Biomed…. Hauptthemen laut MEDLINE: Immunotherapy, Infrared Rays, Genetic Engineering, Nanoparticles. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Outstanding Young Scientist Program.
Abstract (Originalsprache)
The combination of nanoparticles and tumor‐targeting bacteria for cancer immunotherapy can overcome the shortcomings of poor nanoparticle accumulation, limited penetration, and restricted distribution. However, it remains a great challenge for the hybrid system to improve therapeutic efficacy through the simultaneous and controllable regulation of immune cells and tumor cells. Herein, a hybrid therapeutic platform is rationally designed to achieve immune cascade‐augmented cancer immunotherapy. To construct the hybrids, photothermal nanoparticles responsive to light in the second near‐infrared (NIR‐II) region are conjugated onto the surface of engineered bacteria through pH‐responsive Schiff base bonds. Taking advantage of the hypoxia targeting and deep penetration characteristics of the bacteria, the hybrids can accumulate at tumor sites. Then nanoparticles detach from the bacteria to realize genetic engineering of tumor cells, which induces tumor cell apoptosis and down‐regulate the expression of programmed cell death ligand 1 to alleviate immunosuppressive tumor microenvironment. The mild photothermal heating can not only induce tumor‐associated antigen release, but also trigger sustainable expression of cytokine interleukin‐2. Notably, a synergistic antitumor effect is achieved between the process of p53 transfection and NIR‐II light‐activated genetic engineering of bacteria. This work proposes a facile strategy for the construction of hybrid system to achieve cascade‐augmented cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Key Laboratory of Biomedical Materials of Natural Macromolecules, Beijing Laboratory of Biomedical Materials, College of Materials Sciences and Engineering, Beijing…
ORCID-Profile: Nana Zhao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Outstanding Young Scientist Program
Zitieren
APA
Dai, X., Liu, Z., Zhao, X., Guo, K., Ding, X., Xu, F. J., & Zhao, N. (2024). NIR‐II‐Responsive Hybrid System Achieves Cascade‐Augmented Antitumor Immunity via Genetic Engineering of Both Bacteria and Tumor Cells. Advanced Materials. https://doi.org/10.1002/adma.202407927
Vancouver
Dai X, Liu Z, Zhao X, Guo K, Ding X, Xu FJ, et al. NIR‐II‐Responsive Hybrid System Achieves Cascade‐Augmented Antitumor Immunity via Genetic Engineering of Both Bacteria and Tumor Cells. Advanced Materials. 2024. doi:10.1002/adma.202407927
BibTeX
@article{Dai2024,
author = {Dai, Xiaoguang and Liu, Zhiwen and Zhao, Xiaoyi and Guo, Kangli and Ding, Xiaokang and Xu, Fu-Jian and Zhao, Nana},
title = {NIR‐II‐Responsive Hybrid System Achieves Cascade‐Augmented Antitumor Immunity via Genetic Engineering of Both Bacteria and Tumor Cells},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202407927}
}
EUVIMED